SCHEMBL3558501

SCHEMBL3558501

CN(C)CCOc1c(-c2ccccc2)[nH]c2c(Cl)cc(Cl)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.41
MAPT P10636 1/20 0.40
HTR7 P34969 2/20 0.40
KDM4E B2RXH2 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
TUBB4A P04350 2/20 0.39
TUBB P07437 2/20 0.39
TUBA3C P0DPH7 2/20 0.39
TUBA1B P68363 2/20 0.39
TUBA4A P68366 2/20 0.39
TUBB4B P68371 2/20 0.39
TUBB3 Q13509 2/20 0.39
TUBB2A Q13885 2/20 0.39
TUBB8 Q3ZCM7 2/20 0.39
TUBA3E Q6PEY2 2/20 0.39
TUBA1A Q71U36 2/20 0.39
TUBA1C Q9BQE3 2/20 0.39
TUBB6 Q9BUF5 2/20 0.39
TUBB2B Q9BVA1 2/20 0.39
TUBB1 Q9H4B7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3564100 0.88 HTR7 (0.40) PDE10AMAPTHTR7KDM4ETUBB4A
SCHEMBL3553981 0.82 PDE10A (0.59) PDE10AHTR7TUBB4ATUBBTUBA3C
SCHEMBL3555171 0.82 PDE10A (0.50) PDE10AHTR7KDM4ETUBB4ATUBB
SCHEMBL3561474 0.80 MAPT (0.46) MAPTHTR7KDM4ETDP1ALDH1A1
SCHEMBL3555901 0.79 HTR2A (0.58) HTR7HTR2AHTR2CALDH1A1ESR1
SCHEMBL3558001 0.79 HTR7 (0.42) HTR7KDM4ETUBB4ATUBBTUBA3C
SCHEMBL855097 0.74 TNKS (0.50) HTR7KDM4EHTR2AHTR2CALDH1A1
SCHEMBL3565415 0.72 TUBB4A (0.49) PDE10AHTR7KDM4ETUBB4ATUBB
SCHEMBL3563594 0.71 HTR6 (0.67) MAPTHTR7KDM4ETUBB4ATUBB
SCHEMBL8923426 0.71 CYP1A2 (0.48) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT PDE10A 2655/4885MAPT 1145/4885HTR7 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.